* MiMedx Group Inc MDXG.OQ MDXG.O is expected to show a
rise
in quarterly revenue when it reports results on April 30 for
the period ending March 31 2024
* The Marietta Georgia-based company is expected to report
a
10.7% increase in revenue to $79.361 million from $71.68 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for MiMedx Group Inc is for
earnings of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MiMedx
Group Inc
is $12.00, above its last closing price of $6.25.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.07 0.07 0.32 Beat 357.1
Sep. 30 2023 0.04 0.05 0.06 Beat 33.3
Jun. 30 2023 -0.02 -0.02 0.00 Beat 100
Mar. 31 2023 -0.08 -0.09 -0.06 Beat 30.8
Dec. -0.04 -0.04 -0.02 Beat 45.5
31 2022
Sep. 30 2022 -0.07 -0.08 -0.09 Missed -16.1
Jun. 30 2022 -0.05 -0.06 -0.11 Missed -94.1
Mar. 31 2022 -0.10 -0.10 -0.11 Missed -10
This summary was machine generated April 26 at 21:08 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)